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I am honored to be asked to give the Brody Memorial Lecture. From those 
of you who knew him personally or are in some way his intellectual descen-
dents, I have learned enough about Sam Brody to recognize that he was a 
remarkable person, with a wide range of interests, many of which are reflected 
in current research at this institution. Among those interests, I understand, 
was the problem of the physiology of stress. 
My own approach to this subject has been a gradual one. It began with my 
research on the molecular mechanisms of action of glucocorticoids which, 
together with the challenge of explaining glucocorticoid physiology to medical 
students, made me aware that there is a very simple and fundamental question 
that has yet to receive a satisfactory answer. 
The question is, what are the physiological functions of glucocorticoids? 
For almost half a century glucocorticoids have been extensively used therapeu-
tically, probably on a larger scale than any other hormone, and have found 
application in treatment of disorders ranging from poison ivy rash to lympho-
cytic leukemias. The related question of whether glucocorticoids have any 
essential function at all is usually answered with an emphatic yes, because 
without glucocorticoids we die. Why we die, however, is far from clear. 
This enigma of glucocorticoid function is also implicit in the mechanisms 
by which secretion of glucocorticoids is regulated. Figure 1 shows a gener-
ally accepted scheme that, except for the inclusion of corticotropin releasing 
factor (CRF), could date back over 40 years. From this scheme follow several 
conclusions. First, in contrast to hormones like aldosterone and insulin, 
glucocorticoids are regulated through negative feedback via their own levels, 
not via their peripheral effects. Whereas insulin's physiologically vital 
function of regulating blood glucose is reflected by the central role of glu-
cose in regulating insulin secretion, no comparable physiological parameter 
regulates glucocorticoids; they exert negative feedback through CRF and adre-
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nocorticotropin (ACTH), which in this scheme simply transmit information on 
glucocorticoid levels from the hypothalamus and hypophysis to the adrenal cor-
tex. 
Many meanings can be read into this form of regulation. Perhaps the 
simplest is that at the basal levels usually set by the feedback system, 
glucocorticoids maintain or modulate a wide range of physiological, cellular 
and metabolic processes, for none of which they necessarily function as prime 
regulators. That interpretation accords with what is known about the effects 
of basal levels of glucocorticoids, which can be elicited under conditions of 
glucocorticoid deficiency with physiological replacement doses of 
glucocorticoids . They include negative feedback modulation of CRF and ACTH; 
maintenance of blood glucose and liver glycogen levels; maintenance of 
cardiovascular function, blood pressure, muscle work capacity; excretion of 
water loads; permissive effects on pressor, lipolytic and gluconeogenic 
activities of hormones; and protection against moderate stress. How they are 
influenced by the normal diurnal and episodic variations in glucocorticoid 
levels is not known. 
Glucocorticoids and Stress 
Superimposed on the feedback loop in Figure 1 is the influence of 
"stress." Stress caused by almost any challenge to homeostasis- injury, 
infection, fear - stimulates secretion of CRF, ACTH and glucocorticoids. 
Stress-induced levels of glucocorticoids, in turn , appear to be essential for 
survival in the face of severe stress. This mutual relation between glucocor-
ticoids and stress was much debated during the 1940's and SO's in connection 
with the work and theories of Hans Selye (Selye, 1947), the main proponent and 
popularizer of the concept of stress, and seemed for a time to hold out an 
answer to the question of the physiological function of glucocorticoids: they 
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were there primarily to protect against stress. In that light, Figure 1 can 
be viewed as including a larger negative feedback loop in which stress 
increases the levels of glucocorticoids, and glucocorticoids somehow diminish 
stress. 
For reasons my colleagues, Paul Guyre and Nikki Holbrook, and I have 
discussed in a recent review (Munck, Guyre and Holbrook, 1984) , although the 
protective role of glucocorticoids in stress is still strongly emphasized for 
glucocorticoid therapy, it long ago ceased to occupy a central position in 
glucocorticoid physiology. At the acute high levels found in conditions of 
stress, glucocorticoids exert widespread actions that are mostly inhibitory. 
They. suppress synthesis of CRF and ACTH, and also of the antidiuretic hormone 
and ~-endorphin. They antagonize insulin, raising blood glucose levels. They 
suppress immune responses and inflammation. They cause lysis of lymphocytes. 
-----·· .. 
At the same time they induce a number of enzymes, and they protect against 
severe stress. 
Early attempts to explain how glucocort i coids protect against stress were 
not very successful. For example, the elevation of blood glucose was 
hypothesized to provide extra energy for muscle work and other functions, but 
where tested, glucose could not replace glucocorticoids. Another early 
hypothesis, that lympholysis allowed rapid release from lymphocytes of 
preformed antibodies to combat infection, also found little experimental 
support. 
With the discovery in the late 1940's of the anti i nflammatory effects, 
both Selye's theories and glucocorticoid physiology faced acute crises . Those 
effects of high doses of glucocorticoids were completely contrary not only to 
the tenets of Selye's theory of diseases of adaption, which held that 
overactivity of the adrenal cortex was an etiologic factor in disorders such 
as rheumatoid arthritis, but also to the general belief among physiologists 
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that glucocorticoids protected against stress by stimulating normal defense 
mechanisms. The antiinflammatory effects demonstrated that glucocorticoids 
relieved rather than exacerbated the symptoms of rheumatoid arthritis, and did 
so by suppressing rather than stimulating a normal defense mechanism, 
inflammation. 
Endocrinologists, unable to accommodate the antiinflammatory actions 
within the then current framework of glucocorticoid physiology, in effect 
proscribed them from physiology by branding them as "pharmacological." These 
actions, along with many other pharmacological actions discovered in the 
explosion of investigation that followed, vastly extended the range of 
therapeutic applications of glucocorticoids and soon came to dominate 
glucocorticoid endocrinology. Most of those therapeutic applications were 
generally assumed to have no basis in physiology. That anomalous situation, 
probably unique among hormones, still prevails today. 
Understanding of the physiological role of glucocorticoids since that time 
not only has failed to keep up with clinical applications but if anything has 
diminished. Recent decades have seen important discoveries at the molecular 
and cellular level, including those of glucocorticoid receptors and their 
involvement in gene regulation. As a sidelight, these studies have begun to 
show that contrary to widely held opinion, pharmacological and physiological 
effects are probably initiated through identical receptor-mediated mechanisms. 
Glucocorticoids have also been found to exert direct, specific effects at 
physiological concentrations on almost all mammalian cells that have been 
tested. These effects, again mostly inhibitory, have proved as difficult as 
the antiinflammatory effects to reconcile with the traditional view that 
glucocorticoids enhance defenses against stress. 
Results of the last 10 years or so have begun to reveal that 
glucocorticoids exert many of their inhibitory effects by blocking the 
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production or action of intercellular mediators such as the prostanoids 
(prostaglandins and other arachidonic acid metabolites) and cytokines 
(lymphokines and monokines, peptide products of lymphocytes and monocytes, 
respectively). We see a parallel here to the well-known inhibitory effects of 
glucocorticoids on hormones such as insulin , antidiuretic hormone, CRF and 
ACTH, and on ~-endorphin and other peptides that are linked to ACTH through a 
common precursor. Figure 2 illustrates this extended view of glucocorticoid 
physiology, according to which many important effects of glucocorticoids are 
secondary, propagated and amplified through a network of mediators under 
glucocorticoid control. 
These widespread inhibitory effects of glucocorticoids have led me and my 
colleagues to a hypothesis on functions of glucocorticoids in stress that is 
almost the reverse of the traditional view that glucocorticoids protect by 
enhancing defense mechanisms. As discussed below in more detail, the 
hypothesis proposes that glucocorticoids protect against stress by suppressing 
defense mechanisms, thus preventing them from overshooting. When we view the 
full range of actions of glucocorticoids in the light of this physiological 
hypothesis, we discover in many of them an underlying unity hitherto obscured 
by the exclusion from physiology of pharmacological effects. 
Glucocorticoid Modulation of Stress-induced Mediators of Immune and 
Inflammatory Reactions . 
Among the substances whose production is inhibited by the high levels of 
glucocorticoids that occur under the stimulus of stress is a host of compounds 
that mediate inflammatory or immune responses. Some of these will be 
discussed briefly to indicate how widespread is the inhibition. 
T-lymphocytes and monocytes, when stimulated or activated in various ways, 
secrete lymphokines or monokines that stimulate other cells to participate in 
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the response. Interleukin-1 (IL-l), produced by activated monocytes, exists 
in two forms with little amino acid sequence similarity but with apparently 
identical activities mediated through the same receptor. It elicits the fever 
response in the hypothalamus, probably stimulates rheumatoid synovial 
fibroblasts to secrete potentially injurious collagenase and E-prostaglandin , 
stimulates production of acute phase reactants such as fibrinogen and 
activates T-lymphocytes (Dinarello et al., 1986). Tumor necrosis factor ( TNF ) 
or cachectin, also a product of activated monocytes, shares many of these 
activities of IL-l including fever production and stimulation of acute phase 
reactants (but not activation of T-lymphocytes), and has been implicated as a 
mediator of endotoxic shock (Beutler and Cerami, 1986). Production of both 
IL-l and tumor necrosis factor is blocked by glucocorticoids. 
Activated T-lymphocytes produce interleukin-2, colony stimulating factor 
and immune interferon. Production of all these lymphokines is blocked by 
glucocorticoids. Interleukin-2 is a growth factor that stimulates 
proliferation of T-lymphocytes for cell-mediated immune responses, and is 
also involved in the development by B-lymphocytes of the antibody-mediated 
humoral immune response. Colony stimulating factors stimulate the 
proliferation of granulocytes and macrophages from immature precursors. 
Immune interferon has several functions besides its classical antiviral 
action: it activates macrophages to lyse tumor cells , it stimulates 
B-lymphocyte differentiation to plasma cells, and, as Paul Guyre has · shown, it 
increases the number of so-called Fe receptors on the surface of macrophages . 
Fe receptors bind immunoglobulin G, and are important in enabling the 
macrophages to recognize invading antigens and to engulf opsonized bacteria. 
By blocking the production of immune interferon, glucocorticoids can 
potentially inhibit all these responses. 
A subpopulation of normal T-lymphocytes has a natural killer property that 
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allows them to lyse tumor cells, possibly an important feature of normal 
cancer surveillance. This property is enhanced by immune interferon and, as 
Nikki Holbrook has shown, is impaired by glucocorticoids. This impairment 
seems to be due to inhibition of both secretion of immune interferon and 
interferon activation of natural killer cells. 
I have expanded on the role of lymphokines and monokines because my own 
work and that of my colleagues has been concentrated here. However, it is 
also known that glucocorticoids inhibit the production or actions of many 
other immune and inflammatory mediators, including prostaglandins, 
leukotrienes, thromboxanes, bradykinin, serotonin, histamine, plasminogen 
activator and collagenase. 
The significance for physiology and therapy of inhibition by 
glucocorticoids of cytokines and inflammatory agents has only begun to be 
explored in vivo, but there is little doubt that those effects would go a long 
way towards explaining the immunosuppressive and antiinflammatory activities 
of the hormones, and in addition may offer opportunities for dealing 
selectively with unwanted side effects of glucocorticoid therapy. Now that 
most of the cytokines mentioned have been fully characterized and are being 
produced by recombinant DNA technology, we can expect rapid progress in this 
area. 
Hypothesis on Glucocorticoid Functions in Stress 
The mediators - hormones, neuropeptides, cytokines, inflammatory agents -
that are suppressed by acute high levels of glucocorticoids share two 
characteristics: all are induced by the stress of such threats to homeostasis 
as hemorrhage, pain, metabolic disorders and infection, and all appear to 
function as important elements of one or more physiological defense 
mechanisms. 
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These observations, together with much work I have not discussed here, 
present overwhelming evidence that glucocorticoids generally suppress defense 
mechanisms, rather than enhance them as assumed in the traditional view. The 
time, therefore, appears to have come to accept these phenomena, along with 
antiinflammatory and related effects, as valid manifestations of physiological 
functions of glucocorticoids. 
The alternative to the traditional view that my colleagues and I have 
proposed is almost its opposite, namely, that what the glucocorticoids really 
protect us from in stress is our own defense mechanisms. More specifically, 
we have proposed that stress-induced levels of glucocorticoids function mainly 
to protect the organisms from potentially dangerous overactivity of the 
defense mechanisms activated in stress, and that they accomplish that function 
by suppressing the defense mechanisms. 
What benefits are conferred on the organism by suppressing these defense 
reactions becomes evident when one considers that almost all mediators and 
normal defense reactions mobilized against stresses of various kinds can 
become toxic to the organism and cause damage if they remain active for long 
periods. In our hypothesis the main role of stress-induced glucocorticoids is 
to prevent that from happening. 
Such a role appears plausible and has already been proposed for several 
glucocorticoid actions. As early as 1951 a similar hypothesis was 
advanced by Marius Tausk in Holland (Tausk, 1951). That antiinflammatory 
actions can protect against overactivity in inflammatory responses is self-
evident. Hugo Besedovsky and his colleagues from the Swiss Research Institute 
in Davos have suggested that glucocorticoids help prevent a normal immune 
response from developing into autoimmunity (Besedovsky, del Rey and Sorkin, 
1983). Hans Selye tentatively advanced similar ideas in some of his last 
writings on immunosuppressive actions (Selye, 1976). Defronzo et al. (1980) 
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have pointed out that glucocorticoids, along with glucagon and the catechola-
mines, can be regarded as counterregulatory to insulin, acting by a variety of 
mechanisms to prevent potentially fatal insulin hypoglycemia. We have pro-
posed that promotion by glucocorticoids of water excretion could prevent 
excessive water retention and possible water intoxication following a response 
to stress. That beneficial effects of glucocorticoids in shock may in part be 
due to their ability to counteract excessive vasoconstriction and toxicity by 
catecholamines has been known for a long time. Beneficial effects in endo-
toxic shock have recently been proposed to be due to suppression of production 
( Be-..t\cr -J CetO."M~, 1'\?>~) 
of tumor necrosis factorA Certain enzymes rapidly induced by glucocorticoids 
may serve to detoxify stress-induced mediators like glutamine and serotonin, 
the latter having been suggested many years ago (c.f. Munck et al., 1984). 
This brief survey is intended to show that at the same time as our 
hypothesis removes the barriers that for 35 years have excluded 
antiinflammatory and other pharmacological effects from glucocorticoid 
physiology, it reveals an unexpected unity among many fundamental actions of 
glucocorticoids. Furthermore, it invokes specific, testable mechanisms by 
which glucocorticoids protect against stress, and begins to suggest answers to 
some of the questions that have preoccupied glucocorticoid physiologists for 
half a century. 
Although it is perhaps remarkable that, without doing violence to the 
facts, such diverse actions of glucocorticoids as those on immune reactions , 
carbohydrate metabolism and water balance can be interpreted within the same 
framework, nothing in the hypothesis requires that all actions of 
stress-induced levels of glucocorticoids should conform to a single pattern. 
Nature advances opportunistically, and many other uses are conceivable for 
glucocorticoids in stress besides suppression of defense reactions . It is 
also evident that nature has many ways of controlling individual defense 
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reactions besides glucocorticoids. What the glucocorticoids appear to do is 
function as broad-spectrum damping agents, providing the organisms with 
blanket coverage against overactivity of defense reactions. 
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